SonoSite acquisition by Fujifilm finalised

SonoSite has become a wholly-owned subsidiary of Fujifilm following the completion of a merger agreement process commenced in December 2011.

Fujifilm has acquired the medical technology firm via a wholly-owned US subsidiary known as Salmon Acquisition Corporation, which has been merged into SonoSite as part of the takeover process.

Common stock in SonoSite ceased trading on March 29th 2012, meaning it is now officially a part of a leading diversified technology group with an international presence and interests in the healthcare, imaging and functional materials sectors.

In total, Fujifilm has paid around $995 million (620.5 million pounds) to purchase SonoSite, which will continue to operate under its existing management team following the merger.

The deal will allow the organisations to combine capabilities, thus driving global growth and facilitating the delivery of high-quality products and services to patients.

SonoSite president and chief executive officer Kevin Goodwin expressed confidence that the takeover will help the business to respond better to the "fast-evolving needs of physicians".